Abstract: Slide Presentations |

Once-daily, High-dose Inhaled Fluticasone Propionate in Patients having Moderate Asthma FREE TO VIEW

Sudhir K. Agarwal, MD
Author and Funding Information

Institute of Medical Sciences, BHU, Varanasi, India


Chest. 2003;124(4_MeetingAbstracts):88S. doi:10.1378/chest.124.4_MeetingAbstracts.88S-a
Text Size: A A A
Published online


PURPOSE:  Inhaled corticosteroids (ICS) are the mainstay of asthma treatment, but are underprescribed and their effectiveness is compromised by low patient compliance. Current ICS are recommended for use 2 or more times per day, making compliance problematic. The current study assessed the compliance and efficacy of once-daily inhaled fluticasone propionate in Indian patients of Eastern Uttar Pradesh having moderate asthma.

METHODS:  The efficacy of inhaled fluticasone propionate (FP) at a dose of 500 μg and salmeterol 50 μg once a day was compared with fluticasone propionate 250 μg and salmeterol 50 μg twice a day in moderate asthma. A total of 280 asthmatics aged 16 to 45 years were randomized to receive either fluticasone with salmeterol once a day or FP with salmeterol twice a day for 3 months by accuhaler.During the study, the patients were recorded morning and evening peak expiratory flow (PEF), symptom score and use of rescue salbutamol. Pulmonary function parameters were measured at the beginning of the study after the first, fourth, eighth and twelve weeks.

RESULTS:  At the end of twelve weeks, in comparison with FP + salmeterol once a day resulted in higher FEV1/FVC (p=0.016) and lower diurnal variability of PEF (p=0.038). The number of puffs of rescue salbutamol was also significantly lower. Compliance at the end of therapy was 84% in once daily therapy as compared to 48% in twice a day treatment ( p<0.001).

CONCLUSION:  Using a once-daily fluticasone increases effectiveness of asthma treatment as compared to twice a day treatment.

CLINICAL IMPLICATIONS:  Once-daily fluticasone may be tried in patients having moderate asthma to improve compliance and to improve efficacy of asthma treatment.

DISCLOSURE:  S.K. Agarwal, None.

Monday, October 27, 2003

2:30 PM - 4:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Inhaled corticosteroids for the treatment of chronic asthma in children under the age of 12 years.
National Institute for Health and Clinical Excellence (NICE) | 1/31/2008
Long-term management of asthma.
Finnish Medical Society Duodecim | 1/11/2008
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543